Engineered T Cell Receptors With Built-In ICOS Deliver Long-Lasting Anti-Tumor Power
Researchers have engineered T cell receptors fused to the co-stimulatory molecule ICOS, producing T cells that persist longer, resist exhaustion ...
Researchers have engineered T cell receptors fused to the co-stimulatory molecule ICOS, producing T cells that persist longer, resist exhaustion ...
A new computational pipeline translates single-cell immune fingerprints from triple-negative breast cancer patients into ranked engineering recommendations for synthetic immune ...
A specialized APOE-producing Kupffer cell population in transplanted livers restrains rejection by driving attacking CD8-positive tissue-resident memory T cells into ...
Researchers have identified ANKRD11 as a chromatin regulator whose loss reprograms CD8+ T cells to fight chronic hepatitis B and ...
When the immune system battles a persistent viral infection, its most important foot soldiers—CD8+ T cells—face a fate decision within ...
Tertiary lymphoid structures (TLSs)—immune-cell aggregates that form in many solid tumours—have been linked to better outcomes from immune checkpoint blockade. ...
In a dramatic revelation that challenges conventional thinking about cell biology, scientists report that cancer cells can effectively “poison” the ...
In the evolving landscape of cancer treatment, the intricate interaction between immune cells and tumor microenvironments remains a focal point ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine